Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radek Spisek

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Expert Opinion on Investigational Drugs|June 1, 2026
SOT201: <i>cis</i>-acting PD-1/IL-15 mutein-based immunocytokine under investigational study in solid tumorsVladyslav Mazhara, Irfan Baki Kilic, Irena Adkins, et al.
Oncoimmunology|June 23, 2017
Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cellsIrena Adkins, Lenka Sadilkova, Nada Hradilova, et al.
Immunology Letters|April 15, 2014
Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCsIva Truxova, Katerina Pokorna, Kamila Kloudova, et al.
Vaccine|July 13, 2004
Maturation of dendritic cells by bacterial immunomodulatorsRadek Spisek, Jitka Brazova, Daniela Rozkova, et al.
Biotechnology Advances|February 8, 2018
High hydrostatic pressure in cancer immunotherapy and biomedicineIrena Adkins, Nada Hradilova, Ondrej Palata, et al.
Immunology Letters|November 28, 2017
Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancerJitka Fucikova, Lenka Kasikova, Iva Truxova, et al.
Blood|February 15, 2007
Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implicationsRadek Spisek, Anna Charalambous, Amitabha Mazumder, et al.
Blood|August 19, 2007
Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursorsSayuri Yamazaki, Anthony J Bonito, Radek Spisek, et al.
Journal for Immunotherapy of Cancer|October 14, 2021
Immunological configuration of ovarian carcinoma: features and impact on disease outcomeJitka Fucikova, An Coosemans, Sandra Orsulic, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2003
Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulationRadek Spisek, Gwenola Bougras, Frederic Ebstein, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|June 1, 2026
SOT201: <i>cis</i>-acting PD-1/IL-15 mutein-based immunocytokine under investigational study in solid tumorsVladyslav Mazhara, Irfan Baki Kilic, Irena Adkins, et al.
Oncoimmunology|June 23, 2017
Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cellsIrena Adkins, Lenka Sadilkova, Nada Hradilova, et al.
Immunology Letters|April 15, 2014
Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCsIva Truxova, Katerina Pokorna, Kamila Kloudova, et al.
Vaccine|July 13, 2004
Maturation of dendritic cells by bacterial immunomodulatorsRadek Spisek, Jitka Brazova, Daniela Rozkova, et al.
Biotechnology Advances|February 8, 2018
High hydrostatic pressure in cancer immunotherapy and biomedicineIrena Adkins, Nada Hradilova, Ondrej Palata, et al.
Immunology Letters|November 28, 2017
Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancerJitka Fucikova, Lenka Kasikova, Iva Truxova, et al.
Blood|February 15, 2007
Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implicationsRadek Spisek, Anna Charalambous, Amitabha Mazumder, et al.
Blood|August 19, 2007
Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursorsSayuri Yamazaki, Anthony J Bonito, Radek Spisek, et al.
Journal for Immunotherapy of Cancer|October 14, 2021
Immunological configuration of ovarian carcinoma: features and impact on disease outcomeJitka Fucikova, An Coosemans, Sandra Orsulic, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2003
Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulationRadek Spisek, Gwenola Bougras, Frederic Ebstein, et al.
Pageof 9